aspsirna3069 details

Purple = Wild vs mutant target sequence along with mutation information
Brown= Wild vs ASP-siRNA description along with positional differnece between two
Light pink= ASP siRNA efficacy for mutant vs wild allele
Green= Wild siRNA efficacy for Wild vs Mutant allele
siRNA Id:aspsirna3069
siRNA Name: TGFBI-Arg124Cys-14
Gene:Transforming growth factor beta induced (TGFBI)
Disease:Lattice corneal dystrophy type I (LCDI)
Wild allele/target (5'->3'): CGGACCGCACGGAGAAGCU
Mutant allele/target (5'->3'):CGGACUGCACGGAGAAGCU
Target Mutation: c.370C>T,p.Arg124Cys
Wild siRNA (As strand):GCCUGGCGUGCCUCUUCGA
ASP-siRNA (As strand):GCCUGACGUGCCUCUUCGA
Mismatch position in siRNA: A14G
Mutant allele (5'->3'): CGGACUGCACGGAGAAGCU
ASP-siRNA (As strand):GCCUGACGUGCCUCUUCGA
ASP-siRNA efficacy for mutant allele:50
Wild allele (5'->3'): CGGACCGCACGGAGAAGCU
ASP-siRNA (As strand):GCCUGACGUGCCUCUUCGA
ASP-siRNA efficacy for wild allele:10
Percentage discrimination for ASP-siRNA:40
Wild allele (5'->3'): CGGACCGCACGGAGAAGCU
Wild siRNA (As strand):GCCUGGCGUGCCUCUUCGA
Wild sirna efficacy for wild allele:50
Wild allele (5'->3'): CGGACCGCACGGAGAAGCU
ASP-siRNA (As strand):GCCUGACGUGCCUCUUCGA
Wild sirna efficacy for mutant allele:45
Percentage discrimination for wild siRNA:5
Concentration:6.25 nM
Orientation:Sense
Mismatch in:siRNA
UniProt ID: Q15582
Target sequence: ACUCAGCUGUACACGGACC
Genbank Accesion: NM_000358.2
Cell-line: LCDI ex vivo model
Experimental technique used: RT-PCR
Transfection method: Lipofectamine 2000
siRNA expression method: MWG Biotech
Post-transfection duration: 72 hours
OMID ID: 122200
KEGG disease ID:H00956
Reference:24425855

.
.
.
.
.
.
.
.
.
.
.

.

.

.